Spontaneous intra-abdominal hemorrhage of a well-differentiated, grade 3 gastric neuroendocrine tumor during drug-based treatment
- 11 May 2021
- journal article
- case report
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 14 (4) , 1244-1249
Abstract
Grade 3, well-differentiated, gastric neuroendocrine tumors (NET G3) are extremely rare. Herein, we report the case of a 64-year-old man with a grade 3 neuroendocrine tumor of the stomach who experienced intra-abdominal bleeding during the course of drug treatment. The patient was referred to our hospital for examination of a gastric tumor that was initially diagnosed by a local medical doctor. Esophagogastroduodenoscopy revealed an elevated lesion with a central ulcer in the upper body of the stomach, and biopsy specimens confirmed the pathological diagnosis of NET G3. Abdominal contrast-enhanced computed tomography (CT) showed a 25-cm, well-defined mass lesion showing heterogeneous enhancement in the liver. A clinical diagnosis of NET G3 with multiple liver metastases was given, after which everolimus was administered in combination with a somatostatin analogue. However, the patient developed sudden-onset epigastric abdominal pain and general fatigue 2 months later, and emergency abdominal contrast-enhanced CT confirmed the presence of intra-abdominal hemorrhage. Following blood transfusion, the patient’s symptoms and general condition improved. Although the patient was treated with streptozocin, abdominal CT indicated progression of the liver metastases. Unfortunately, despite receiving best supportive care, the patient died 8 months after the initial of the treatment. To the best of our knowledge, this is the first case of a patient who developed spontaneous hemoperitoneum during drug treatment for a NET G3 to be reported in the English literature. It is essential that additional data be obtained to determine the optimal treatment for this disease.Keywords
This publication has 31 references indexed in Scilit:
- Management of bleeding liver tumorsJournal of Visceral Surgery, 2014
- Spontaneous rupture of hepatic metastasis from small cell neuroendocrine carcinoma of maxillary sinusWorld Journal of Surgical Oncology, 2014
- Risk factors for bleeding in hepatocellular adenomaBritish Journal of Surgery, 2014
- A Spontaneously Ruptured Hepatic Metastasis From a Gastric Gastrointestinal Stromal Tumor That Presented as HemoperitoneumJournal of Investigative Medicine High Impact Case Reports, 2013
- Neuroendocrine carcinoma of the stomach: clinicopathological and immunohistochemical evaluationMedical Molecular Morphology, 2013
- Surgery for a gastroenteropancreatic neuroendocrine tumor (GEPNET) in multiple endocrine neoplasia type 1Surgery Today, 2012
- Primary Hepatic Choriocarcinoma: A Rare Cause of Spontaneous Haemoperitoneum in an AdultClinics and Practice, 2012
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 studyThe Lancet, 2011
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Primary gastric small cell carcinoma: report of a case and review of the literatureMedical Molecular Morphology, 2005